众生药业 (002317)

Guangdong Zhongsheng Pharmaceutical Co.,Ltd.

ASZ

Tags

Nicotinamide Mononucleotide (NMN) ConceptGeneric DrugsElderly Care ConceptWeight Loss DrugsInnovative DrugsPharmaceutical ManufacturingHelicobacter PyloriSmart HealthcareGuangdong-Hong Kong-Macao Greater Bay AreaVitaminsHepatitis ConceptMargin Trading and Securities LendingAssisted ReproductionSME 300 Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 84993.05
  • Circulating A-Shares(W): 76161.74
  • Earnings Per Share(RMB): 0.3000
  • Net Assets Per Share(RMB): 4.7415
  • Operating Revenue(W RMB): 188875.39
  • Total Profit(W RMB): 28733.63
  • Net Profit Attributable to Parent(W RMB): 25057.80
  • Net Profit Growth Rate(%): 68.40
  • Weighted Return on Equity(%): 6.3000
  • Operating Cash Flow Per Share(RMB): 0.1820
  • Undistributed Profit Per Share(RMB): 1.1715
  • Capital Reserve Per Share(RMB): 2.1350

2. Main Business

The main business covers:

  • Pharmaceutical R&D
  • Pharmaceutical Production
  • Pharmaceutical Sales

3. Company Basic Information

  • Company Name: Guangdong Zhongsheng Pharmaceutical Co., Ltd.
  • Listing Date: 2009-12-11
  • Industry: Pharmaceutical Manufacturing
  • Address: Information Industry Park, Xihu Industrial Zone, Shilong Town, Dongguan City, Guangdong Province
  • Website: www.zspcl.com
  • Company Profile: The company was established as a joint stock limited company approved by the Guangdong Provincial People's Government General Office Document No. Yue Ban Han [2001]739 and the Guangdong Provincial Economic and Trade Commission Document No. Yue Jing Mao Supervision [2001]1086. The main promoter was the Industrial General Company, jointly initiated with eight natural persons: Zhang Shaori, Ye Huitang, Long Chaofeng, Cao Jiayue, Xiao Yan, Li Yujian, Zhao Xiping, and Huang Shibin. The company was registered with the Guangdong Provincial Administration for Industry and Commerce on December 31, 2001, with registration number 4400001009971 (changed to 440000000014746 on September 28, 2007, due to system upgrade). The registered capital was RMB 32 million.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hong Kong Securities Clearing Company Ltd. Northbound Funds 2264.70 2.97
2 Invesco Great Wall Trend Investment Mixed Securities Investment Fund (LOF) Fund 1646.83 2.16
3 Invesco Great Wall Herun Mixed Securities Investment Fund (LOF) Class A Fund 1092.06 1.43
4 Invesco Great Wall Multi-Dimensional Value Mixed Securities Investment Fund Class A Fund 963.79 1.27
5 National Social Security Fund 604 Portfolio Social Security Fund 804.82 1.06
6 Invesco Great Wall Hefeng Three-Year Holding Period Mixed Securities Investment Fund Fund 777.51 1.02
7 Qianhai Kaiyuan Traditional Chinese Medicine Research Selected Equity Initiated Securities Investment Fund Class A Fund 308.04 0.40
8 CCB High-End Medical Equity Securities Investment Fund Class A Fund 40.36 0.05
9 Dacheng Zhihui Quantitative Multi-Strategy Flexible Allocation Hybrid Securities Investment Fund Class A Fund 2.81 0.00
10 Taixin Smart Selection Quantitative Stock Selection Hybrid Initiated Securities Investment Fund Class A Fund 1.50 0.00

5. Concept Sectors

  • Aging Care Concept
  • Guangdong-Hong Kong-Macao Greater Bay Area
  • Vitamins
  • Intelligent Healthcare
  • Generic Drugs
  • NMN Concept
  • Helicobacter Pylori
  • Assisted Reproduction
  • Hepatitis Concept
  • Innovative Drugs
  • Weight Loss Drugs
  • Margin Trading & Securities Lending
  • SME 300 Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information